Teva Pharmaceutical Industries
TEVA
#638
Rank
NZ$69.94 B
Marketcap
NZ$60.03
Share price
1.58%
Change (1 day)
117.49%
Change (1 year)

EPS for Teva Pharmaceutical Industries (TEVA)

EPS in 2026 (TTM): NZ$2.35

According to Teva Pharmaceutical Industries's latest financial reports the company's current EPS (TTM) is NZ$2.33. In 2025 the company made an earnings per share (EPS) of NZ$2.11 an increase over its 2024 EPS that were of NZ-$2.46.

EPS history for Teva Pharmaceutical Industries from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.3511.5%
2025NZ$2.11-185.52%
2024NZ-$2.46208.51%
2023NZ-$0.80-77.83%
2022NZ-$3.60-657.89%
2021NZ$0.65
2019NZ-$1.56-60.34%
2018NZ-$3.94-85.73%
2017NZ-$27.60-23328.57%
2016NZ$0.12-96.2%
2015NZ$3.12-48.6%
2014NZ$6.08138.67%
2013NZ$2.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.92 412.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.22-4.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.35 86.84%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.07 160.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.80 407.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.60 183.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
NZ$0.99-57.42%๐Ÿ‡ฎ๐Ÿ‡ณ India